STARMED Receives FDA 510(k) Clearance for a Benign Thyroid Nodule Ablation Indication

STARMED Receives FDA 510(k) Clearance for a Benign Thyroid Nodule Ablation Indication

SEOUL, South Korea, July 1, 2026 /PRNewswire/ -- STARMED, a medical device company specialising in minimally invasive treatment technologies, has announced that it has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for a...

menu
menu